Sterile Injectables CDMO Services
US-based expertise, quality, and capacity to advance your program
ForDoz Pharma is focused exclusively on sterile drug products, helping develop and commercialize innovative therapeutics by serving as a contract development and manufacturing organization (CDMO) partner. Based in East Windsor, New Jersey, ForDoz is a fully integrated sterile drug product CDMO with end-to-end capabilities.
Advancing Sterile Drug Products
ForDoz Pharma specializes in conventional formulations and complex sterile drug products:
Conventional aqueous solution products
Lyophilized sterile formulations
Liposomal & nanoparticle-based drug delivery
Microsphere & polymer-based controlled-release systems
in situ depot formulations for long-acting injectables
Along with the ability to work with organic solvents, high-potency compounds, and small or large molecules, our expertise in conventional and complex formulations allows us to address the challenging issues that sterile drug product developers face.
ForDoz Pharma’s Services & Facilities Support the Full Product Lifecycle
Preclinical
- Pre-formulation activities
- Early-phase process development
- Toxicology dosing formulation studies
- Analytical method development
- IND-enabling formulation activities
Phase I – Phase III
- Process development & scale-up
- Clinical trial cGMP manufacturing
- ICH-compliant stability testing
- Release testing
- On-site cGMP storage
- Robust CMC and regulatory support
Commercial
- Process optimization
- Commercial cGMP manufacturing
- Release testing
- On-site cGMP storage
- Interval stability testing support
Facility
cGMP Facilities
- cGMP sterile manufacturing facility, completed FDA PAI in 2023
- In-house cGMP QC lab
- In-house cGMP microbiology lab
- On-site cGMP finished product inspection
- Packaging, labeling, serialization, and aggregation
- On-site cGMP warehouse
Working to Advance Your Conventional and Complex Injectables Program
Let us put our expertise and capacity to work to support the end-to-end needs of your conventional and complex injectable program, from early development and regulatory approval to commercial manufacturing.